API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercebiotech.com/biotech/merck-gileads-weekly-hiv-combo-maintains-viral-suppression-its-early-days-primary-endpoint
https://www.pharmaceutical-technology.com/news/mercks-hiv-pipeline-shifts-as-prep-program-discontinues/
https://www.reuters.com/business/healthcare-pharmaceuticals/merck-start-new-study-low-dose-hiv-drug-after-fdas-hold-2022-09-20/
http://www.pharmafile.com/news/600180/fda-pauses-several-trials-merck-s-investigational-hiv-drug
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-puts-mercks-hiv-drug-trials-hold-2021-12-13/
https://www.fxempire.com/news/article/u-s-fda-puts-mercks-hiv-drug-trials-on-hold-839255
https://www.fiercebiotech.com/biotech/merck-pauses-2-more-trials-backbone-hiv-drug-over-red-flag-raising-doubts-about-multi
https://trialsitenews.com/gilead-and-merck-pause-enrollment-for-phase-2-hiv-study-evaluating-islatravir-days-after-merck-stops-islatravir-combination-study-due-to-safety-concerns/
https://www.fiercebiotech.com/biotech/merck-close-to-regulatory-filings-for-hiv-treatment-combo-shows-comparable-efficacy-to
https://endpts.com/mercks-experimental-hiv-drug-islatravir-hits-with-a-phiii-combo-win-and-fda-filing-plans/
https://www.who.int/news/item/08-09-2021-prep-updates-and-new-products-at-ias-2021